(Q86249873)
Statements
A novel series of tacrine-selegiline hybrids with cholinesterase and monoamine oxidase inhibition activities for the treatment of Alzheimer's disease (English)
Chuanjun Lu
Qi Zhou
Jun Yan
Zhiyun Du
Ling Huang
8 February 2013